Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Indian government has allowed Nutra Pharma to market its over-the-counter pain reliever, Nyloxin line for the treatment of moderate to severe chronic pain.
Subscribe to our email newsletter
Currently, Nyloxin is available as an oral spray in US for joint pain, back pain, neck aches, migraines, headaches and neuralgia and as atopical gel to treat arthritis pain, neck pain, jaoint pain and pain from repetitive stress.
Following the approval, Nutra Pharma is received orders through distributor, Nutritional Alliance, for export to India-based importers.
Nutra Pharma chairman and CEO Rik Deitsch said the India approval is their first regulatory authorization overseas and represents one of the more significant international market opportunities for Nyloxin.